Diagnostic accuracy of a novel point-of-care test for simultaneous detection of anti-transglutaminase IgA and anti-deamidated gliadin IgG antibodies.
anti-deamidated gliadin antibodies
anti-transglutaminase antibodies
case-finding test
celiac disease
early diagnosis
lateral-flow immunochromatography assays
point-of-care testing
screening test
Journal
Journal of clinical laboratory analysis
ISSN: 1098-2825
Titre abrégé: J Clin Lab Anal
Pays: United States
ID NLM: 8801384
Informations de publication
Date de publication:
30 Jan 2024
30 Jan 2024
Historique:
revised:
28
12
2023
received:
10
11
2023
accepted:
01
01
2024
medline:
31
1
2024
pubmed:
31
1
2024
entrez:
31
1
2024
Statut:
aheadofprint
Résumé
Point-of-care tests (POCTs) may have a role in detecting undiagnosed cases of Celiac disease (CD). We assessed the diagnostic accuracy of a novel POCT, compared with the conventional serological methods, for simultaneous anti-transglutaminase (tTG) IgA and anti-deamidated gliadin (DGP) IgG antibody detection. Furthermore, we evaluated the effect of different biological matrices (whole blood and serum) on test performance. Serum and whole blood from celiac or suspected celiac patients who underwent duodenal biopsy were assayed for the presence of anti-tTG IgA and anti-DGP IgG both with the reference standard methods (Thermo Fisher Scientific, Uppsala, Sweden) and with the POCT (PRIMA Lab SA, Balerna, Switzerland). 266 sera (101 negative and 165 positive) and 60 whole blood samples (34 positive and 26 negative) were included in the study. POCT for anti-DGP IgG showed a sensitivity of 84.3% and a specificity of 90.1%, with positive (PPV) and negative predictive values (NPV) of 91.07% and 82.73%. POCT for anti-tTG IgA showed a sensitivity of 98.31% and a specificity of 98.02%, with a PPV and NPV of 98.31% and 98.02%. Test accuracies were 86.94% and 98.17%, respectively. The agreement of the results between the two different matrices showed a strong correlation rate: 95% for anti-DGP IgG and 100% for anti-tTG IgA. The anti-tTG IgA/anti-DGP IgG-based POCT showed good diagnostic accuracy with comparable sensitivities and specificities to reference standard methods in detecting CD in symptomatic patients and could be considered as a mass screening test before referring to conventional serology.
Sections du résumé
BACKGROUND
BACKGROUND
Point-of-care tests (POCTs) may have a role in detecting undiagnosed cases of Celiac disease (CD). We assessed the diagnostic accuracy of a novel POCT, compared with the conventional serological methods, for simultaneous anti-transglutaminase (tTG) IgA and anti-deamidated gliadin (DGP) IgG antibody detection. Furthermore, we evaluated the effect of different biological matrices (whole blood and serum) on test performance.
METHODS
METHODS
Serum and whole blood from celiac or suspected celiac patients who underwent duodenal biopsy were assayed for the presence of anti-tTG IgA and anti-DGP IgG both with the reference standard methods (Thermo Fisher Scientific, Uppsala, Sweden) and with the POCT (PRIMA Lab SA, Balerna, Switzerland).
RESULTS
RESULTS
266 sera (101 negative and 165 positive) and 60 whole blood samples (34 positive and 26 negative) were included in the study. POCT for anti-DGP IgG showed a sensitivity of 84.3% and a specificity of 90.1%, with positive (PPV) and negative predictive values (NPV) of 91.07% and 82.73%. POCT for anti-tTG IgA showed a sensitivity of 98.31% and a specificity of 98.02%, with a PPV and NPV of 98.31% and 98.02%. Test accuracies were 86.94% and 98.17%, respectively. The agreement of the results between the two different matrices showed a strong correlation rate: 95% for anti-DGP IgG and 100% for anti-tTG IgA.
CONCLUSION
CONCLUSIONS
The anti-tTG IgA/anti-DGP IgG-based POCT showed good diagnostic accuracy with comparable sensitivities and specificities to reference standard methods in detecting CD in symptomatic patients and could be considered as a mass screening test before referring to conventional serology.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25003Subventions
Organisme : PRIMA Lab SA
Informations de copyright
© 2024 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC.
Références
Catassi C, Verdu EF, Bai JC, Lionetti E. Coeliac disease. Lancet. 2022;399(10344):2413-2426.
Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43-52.
Singh P, Arora A, Strand TA, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823-836.e2.
Catassi C, Gatti S, Lionetti E. World perspective and celiac disease epidemiology. Dig Dis. 2015;33(2):141-146. doi:10.1159/000369518
Gatti S, Lionetti E, Balanzoni L, et al. Increased prevalence of celiac disease in school-age children in Italy. Clin Gastroenterol Hepatol. 2020;18(3):596-603.
Lionetti E, Pjetraj D, Gatti S, et al. Prevalence and detection rate of celiac disease in Italy: results of a SIGENP multicenter screening in school-age children. Dig Liver Dis. 2023;55(5):608-613.
Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391(10115):70-81. doi:10.1016/S0140-6736(17)31796-8
Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136-160.
Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA, American College of Gastroenterology. American College of Gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108(5):656-676.
Ludvigsson JF, Bai JC, Biagi F, et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63(8):1210-1228.
Husby S, Koletzko S, Korponay-Szabó I, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141-156.
Baraba Dekanić K, Butorac Ahel I, Ružman L, Dolinšek J, Dolinšek J, Palčevski G. Is there a role of using a rapid finger prick antibody test in screening for celiac disease in children? Gastroenterol Res Pract. 2019;2019:4504679. doi:10.1155/2019/4504679
Primavera G, Aiello A, Grosso C, et al. Point-of-care test screening versus case finding for paediatric coeliac disease: a pragmatic study in primary care. Acta Paediatr. 2021;110(1):337-339.
Grode L, Møller Jensen T, Parkner T, et al. Diagnostic accuracy of a point-of-care test for celiac disease antibody screening among infertile patients. Inflamm Intest Dis. 2019;4(3):123-130.
Mašić M, Musil V, Petričević Vidović T, et al. Point-of-care screening for coeliac disease in schoolchildren reveals higher disease prevalence in Croatia. Healthcare (Basel). 2022;11(1):64.
Lau MS, Mooney PD, White WL, et al. Office-based point of care testing (IgA/IgG-deamidated gliadin peptide) for celiac disease. Am J Gastroenterol. 2018;113(8):1238-1246.
Meijer-Boekel C, van den Akker ME, van Bodegom L, et al. Early diagnosis of coeliac disease in the preventive youth health care centres in The Netherlands: study protocol of a case finding study (GLUTENSCREEN). BMJ Paediatr Open. 2021;5(1):e001152.
Singh P, Arora A, Strand TA, et al. Diagnostic accuracy of point of care tests for diagnosing celiac disease: a systematic review and meta-analysis. J Clin Gastroenterol. 2019;53(7):535-542.
Tangermann P, Branchi F, Itzlinger A, et al. Low sensitivity of Simtomax point of care test in detection of celiac disease in a prospective multicenter study. Clin Gastroenterol Hepatol. 2019;17(9):1780-1787.e5.
Bayram RO, Özdemir H, Emsen A, Türk Dağı H, Artaç H. Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in healthy children. Turk J Med Sci. 2019;49(2):497-505.
Khan SR, Chaker L, Ikram MA, Peeters RP, van Hagen PM, Dalm VASH. Determinants and reference ranges of serum immunoglobulins in middle-aged and elderly individuals: a population-based study. J Clin Immunol. 2021;41(8):1902-1914.
Kardar GA, Shams SH, Pourpak Z, Moin M. Normal value of immunoglobulins IgA, IgG, and IgM in Iranian healthy adults, measured by nephelometry. J Immunoassay Immunochem. 2003;24(4):359-367.
Oyeyinka GO, Salimonu LS, Williams AI, et al. Range of normal serum immunoglobulin (IgG, IgA and IgM) values in Nigerians. Afr J Med Med Sci. 1984;13(3-4):169-176.
Yel L. Selective IgA deficiency. J Clin Immunol. 2010;30(1):10-16.
Kumar V, Jarzabek-Chorzelska M, Sulej J, Karnewska K, Farrell T, Jablonska S. Celiac disease and immunoglobulin a deficiency: how effective are the serological methods of diagnosis? Clin Diagn Lab Immunol. 2002;9(6):1295-1300.